Instrumentation for the Coagulation Laboratory
- 858 Downloads
KeywordsInternational Normalize Ratio Platelet Function Activate Clotting Time Clot Lysis Clot Strength
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 4.Point-of-care monitoring of anticoagulation therapy; approved guideline. CLSI document H49-A.Wayne, PA: Clinical and Laboratory Standards Institute, 2004.Google Scholar
- 5.Murray, ET, Fitzmaurice, DA, McCahon, D. Point of care testing for INR monitoring; where are we now? BMJ 2004; 127:373–8.Google Scholar
- 8.Point-of-care connectivity; approved guideline. CLSI document POCT1-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2001.Google Scholar
- 10.Santrach, PJ. Point-of-care hematology, hemostasis, and thrombolysis testing. In: Kost, GJ, editor. Principals and practice of point-of-care testing. Philadelphia: Lippincott Williams & Wilkins, 2002:157–80.Google Scholar
- 11.Kratz, A, Van Cott, EM. Activated clotting time methods and clinical applications. Point of Care 2005; 4:90–4.Google Scholar
- 14.Mousa, SA, Khurana, S, Forsythe, MS. Comparative In Vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists. Arterioscler Thromb Vasc Biol 2000; 20:1162–67.PubMedGoogle Scholar
- 18.Hayward CPM, Harrison P, Cataneo TL, et al. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312–19.PubMedCrossRefGoogle Scholar
© Springer Science+Business Media, LLC 2007